The review to which the booklet refers was published in ATLA 2 and concerned their book, published in 2000. 3 The Greeks had complained when the review was published, and had been offered the opportunity to reply to the review, in ATLA. However, the comment they had wished to make would have been far longer than the original review. They were not willing to shorten it, so it could not be accepted and published.
In their booklet, the Greeks make a number of derogatory comments about FRAME, which they see as "just another example of the incestuous relationship between big business and those claiming to look for replacements for animal models". They go on to say ". . . look where FRAME's support comes from (see Table 1 ). This is a Who's Who of corporations that obtain money or liability protection from animal studies. Is it really feasible to believe that this type of sponsorship comes with no strings attached?".
A number of points arise. Firstly, the booklet could be seen to imply that its authors had to root out the list of companies given. However, that is not the case. This list is regularly published by FRAME, notably in its annual reports, partly because we have a duty to acknowledge our sources of financial support, but no less because we greatly value our working relationships with our industrial company supporters.
Secondly, FRAME is known for its independence and outspokenness, and no donations of any kind would be accepted, if there were any strings attached. Since 1979, when I first became involved with FRAME, I can only recall two occasions when attempts were made to control our activities. One of them took place when we were about to publish a position paper on the use of non-human primates as laboratory animals. A senior scientist in a company told me that, if we went ahead and published it, he would see that all financial support from his company would immediately cease. I was able to point out to him that we received no such support from his company and that, even if we did, his stipulation could not be considered, let alone accepted. On the second occasion, a senior executive from another company said that they would increase their donations to FRAME, but only if we severed our relationships with their competitors. I asked him to leave my office immediately, and he did.
It should also be noted that, in compliance with the UK law on the management of charities, the FRAME Trustees are precluded from receiving any remuneration from FRAME. Thus, we have no personal financial conflicts of interest in making decisions about choosing appropriate sources of funding. The FRAME Trustees freely give their time and expertise to the organisation, because they believe in its objective of eliminating the use of animals in medical research.
Thirdly, the question arises as to who should fund the search for alternatives. It is logical that it should include those who choose to use laboratory animals or, in the case of a number of industries, are required by law to provide laboratory animal data in support of their products. Such people and organisations would also be expected to have knowledge essential to the discovery and evaluation of non-animal procedures for tackling their objectives and for providing data on the safety and quality of products.
The advantage of funding the necessary research through organisations such as FRAME, is that it can be of benefit to medical research and applied research as a whole, rather than serving the interests of individual laboratories or companies. That is the basic tenet of the FRAME Research Programme. 4 Fourthly, it is clear from the booklet that the Greeks do not support the Three Rs concept, because "it is based on the assumption that experiments on animals are valid, that they lead to cures and treatments for human disease, and that all that needs to be done is reduce, refine or replace them with alternatives. All these assumptions are erroneous."
I find it hard to believe that anybody working on alternatives would work according to these assumptions, at least as expressed in this rather dogmatic way. I would say that experiments on animals can be valid, but are not always valid, nor always invalid. We have to be discriminating about specific cases, and must make judgements according to sound scientific criteria. Similarly, experiments on animals can lead to cures for human disease, but not always. Finally, we do not seek merely to reduce, refine or replace -we want better, moremodern, scientifically advanced methods, based on a greater understanding of the cellular and molecular mechanisms underlying human disease. That is why my former Director General at ECVAM preferred to refer to my unit as the European Centre for the Validation of Advanced Methods, rather then the European Centre for the Validation of Alternative Methods.
It is the Greeks themselves who rely on absolute assumptions i.e. that all animal experiments are always invalid, and that they cannot lead to cures and treatments for human disease. That was the thrust of their book, and it was to counter this dogmatism that Dr Festing wrote his original review for ATLA.
The booklet goes on to ". . . question what FRAME is -especially given the fact that different members of the board give very different views on animal models and that the same members give different views depending on whether the audience is public or private."
This raises two further points. Firstly, some time ago, FRAME decided to focus on all the Three Rs, reduction, refinement and replacement, rather than on replacement alone. As a result, it is not surprising that the FRAME Trustees have a range of views, and it could be argued that this is an essential part of the Charity's strength.
However, the accusation that our views are tailored to suit particular audiences is unworthy. I can only speak for myself, of course, but, when I first became involved in the alternatives cause, in about 1975, I decided that I must diligently work out my position on every issue and stick to it, in all circumstances, until I was convinced that it must be modified. As a result, I have made a number of enemies in the antivivisection movement and also among defenders of the freedom to do animal-based research. I also like to think that I have made some friends.
The booklet does admit "that there are people in FRAME who are trying to do the right thing", but adds the rider that "we would be remiss not to point out that there are others with less pure motives", which leads to the need for "housecleaning within the organization". I don't really know what the Greeks meant by that. I am surprised that they can claim to know us so well that such a comment could be considered justifiable.
However, I will concede one point, not about FRAME itself or anybody connected with FRAME, but about support for the Three Rs in general.
In the 1970s and early 1980s, FRAME seemed to be virtually alone in the middle ground, in its advocacy in support for the Three Rs. Now the middle ground is crowded, but how much of this support for the Three Rs involves real commitment, rather than mere lip service? I raised this point during the seminar held at ECVAM just before my retirement, in the following words:
The emerging EU chemicals policy, [5] the ECVAM report [6] and the strategy will also represent a challenge to those in government, administration, science and animal welfare who purport to be supporters of the Three Rs concept, and an opportunity to show that this support is genuine. 7 I should have added industry to my list. I do so now.
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